Row:		Years ended
	Row:	September 28,
2019
	September 29,
2018
	September 30,
2017
Row:Net sales:
Products 	$ 213,883 	$ 225,847 $ 	196,534
Row:Services 	46,291 	39,748 	32,700
Row:Total net sales 	260,174 	265,595 	229,234
Row:Cost of sales:
			Row:Products 	144,996 	148,164 	126,337
Row:Services 	16,786 	15,592 	14,711
Row:Total cost of sales 	161,782 	163,756 	141,048
Row:Gross margin 	98,392 	101,839 	88,186
Row:Operating expenses:
			Row:Research and development 	16,217 	14,236 	11,581
Row:Selling, general and administrative 	18,245 	16,705 	15,261
Row:Total operating expenses 	34,462 	30,941 	26,842
Row:Operating income 	63,930 	70,898 	61,344
Row:Other income/(expense), net 	1,807 	2,005 	2,745
Row:Income before provision for income taxes 	65,737 	72,903 	64,089
Row:Provision for income taxes 	10,481 	13,372 	15,738
Row:Net income 	$ 55,256 	$ 59,531 $ 	48,351
Row:Earnings per share:
			Row:Basic 	$ 11.97 	$ 12.01 $ 	9.27
Row:Diluted 	$ 11.89 	$ 11.91 $ 	9.21
Row:Shares used in computing earnings per share:
			Row:Basic 	4,617,834 	4,955,377 	5,217,242
Row:Diluted 	4,648,913 	5,000,109 	5,251,692
Row:September 28,
	September 29,
Row:2019
	2018
Row:Current assets:
Cash and cash equivalents 	$ 48,844 $ 	25,913
Row:Marketable securities 	51,713 	40,388
Row:Accounts receivable, net 	22,926 	23,186
Row:Inventories 	4,106 	3,956
Row:Vendor non-trade receivables 	22,878 	25,809
Row:Other current assets 	12,352 	12,087
Row:Total current assets 	162,819 	131,339
Row:Non-current assets:
		Row:Marketable securities 	105,341 	170,799
Row:Property, plant and equipment, net 	37,378 	41,304
Row:Other non-current assets 	32,978 	22,283
Row:Total non-current assets 	175,697 	234,386
Row:Total assets 	$ 338,516 $ 	365,725
Row:LIABILITIES AND SHAREHOLDERS’ EQUITY:
		Row:LIABILITIES AND SHAREHOLDERS’ EQUITY:
		Row:Current liabilities:
		Row:Accounts payable $ 	46,236 	$ 55,888
Row:Other current liabilities 	37,720 	33,327
Row:Deferred revenue 	5,522 	5,966
Row:Commercial paper 	5,980 	11,964
Row:Term debt 	10,260 	8,784
Row:Total current liabilities 	105,718 	115,929
Row:Non-current liabilities:
		Row:Term debt 	91,807 	93,735
Row:Other non-current liabilities 	50,503 	48,914
Row:Total non-current liabilities 	142,310 	142,649
Row:Total liabilities 	248,028 	258,578
Row:Common stock and additional paid-in capital, $0.00001 par value: 12,600,000 shares
authorized; 4,443,236 and 4,754,986 shares issued and outstanding, respectively 	45,174 	40,201
Row:Retained earnings 	45,898 	70,400
Row:Accumulated other comprehensive income/(loss) 	(584) 	(3,454)
Row:Total shareholders’ equity 	90,488 	107,147
Row:Total liabilities and shareholders’ equity $ 	338,516 $ 	365,725
Row:Cash, cash equivalents and restricted cash, beginning balances $ 	25,913 	$ 20,289 	$ 20,484
Row:Operating activities:
			Row:Net income 	55,256 	59,531 	48,351
Row:Adjustments to reconcile net income to cash generated by operating activities:
			Row:Depreciation and amortization 	12,547 	10,903 	10,157
Row:Share-based compensation expense 	6,068 	5,340 	4,840
Row:Deferred income tax expense/(benefit) 	(340) 	(32,590) 	5,966
Row:Other 	(652) 	(444) 	(166)
Row:Changes in operating assets and liabilities:
			Row:Accounts receivable, net 	245 	(5,322) 	(2,093)
Row:Inventories 	(289) 	828 	(2,723)
Row:Vendor non-trade receivables 	2,931 	(8,010) 	(4,254)
Row:Other current and non-current assets 	873 	(423) 	(5,318)
Row:Accounts payable 	(1,923) 	9,175 	8,966
Row:Deferred revenue 	(625) 	(3) 	(593)
Row:Other current and non-current liabilities 	(4,700) 	38,449 	1,092
Row:Cash generated by operating activities 	69,391 	77,434 	64,225
Row:Investing activities:
			Row:Purchases of marketable securities 	(39,630) 	(71,356) 	(159,486)
Row:Proceeds from maturities of marketable securities 	40,102 	55,881 	31,775
Row:Proceeds from sales of marketable securities 	56,988 	47,838 	94,564
Row:Payments for acquisition of property, plant and equipment 	(10,495) 	(13,313) 	(12,451)
Row:Payments made in connection with business acquisitions, net 	(624) 	(721) 	(329)
Row:Purchases of non-marketable securities 	(1,001) 	(1,871) 	(521)
Row:Proceeds from non-marketable securities 	1,634 	353 	126
Row:Other 	(1,078) 	(745) 	(124)
Row:Cash generated by/(used in) investing activities 	45,896 	16,066 	(46,446)
Row:Financing activities:
Proceeds from issuance of common stock 	781 	669 	555
Row:Payments for taxes related to net share settlement of equity awards Payments for dividends and dividend equivalents 	(2,817) (14,119) 	(2,527) (13,712) 	(1,874)
(12,769)
Row:Repurchases of common stock 	(66,897) 	(72,738) 	(32,900)
Row:Proceeds from issuance of term debt, net 	6,963 	6,969 	28,662
Row:Repayments of term debt 	(8,805) 	(6,500) 	(3,500)
Row:Proceeds from/(Repayments of) commercial paper, net 	(5,977) 	(37) 	3,852
Row:Other 	(105) 	— 	—
Row:Cash used in financing activities 	(90,976) 	(87,876) 	(17,974)
Row:Increase/(Decrease) in cash, cash equivalents and restricted cash 	24,311 	5,624 	(195)
Row:Cash, cash equivalents and restricted cash, ending balances $ 	50,224 	$ 25,913 	$ 20,289
Row:Supplemental cash flow disclosure:
			Row:Cash paid for income taxes, net $ 	15,263 	$ 10,417 	$ 11,591
Row:Cash paid for interest $ 	3,423 	$ 3,022 	$ 2,092
Row:See accompanying Notes to Consolidated Financial 	Statements.
		